oxaliplatin, capecitabine, radiotherapy

DRUG2 trials

Sponsors

Sanofi, Lund University Hospital

Conditions

Bile Ductus CancerColorectal CancerGall Bladder CancerPancreas CancerRectal NeoplasmsStomach Cancer

Phase 1

Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer

CompletedNCT01016639

Lund University HospitalBile Ductus Cancer, Colorectal Cancer, Gall Bladder Cancer +2

Start: 2003-06-30End: 2009-07-31Updated: 2011-10-17

Phase 2

CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision

CompletedNCT00174616

SanofiRectal Neoplasms

Start: 2003-07-31End: 2007-11-30Updated: 2009-12-07